NCT05687188 Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations
| NCT ID | NCT05687188 |
| Status | Recruiting |
| Phase | — |
| Sponsor | H. Lee Moffitt Cancer Center and Research Institute |
| Condition | Pancreatic Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 125 participants |
| Start Date | 2023-02-22 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 125 participants in total. It began in 2023-02-22 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will evaluate obesity-mediated mechanisms of pancreatic carcinogenesis in minority populations.
Eligibility Criteria
Inclusion Criteria: * Adults 18 years of age or older at time of signing informed consent * Patients who self-report as African American, Non-Hispanic White * Patients who present to the gastrointestinal (GI) clinic, surgery, or endoscopy at a participating Florida Pancreas Collaborative (FPC) site or the University of Mississippi Medical Center (UMMC) with a clinical suspicion or diagnosis of a pancreatic tumor. Exclusion Criteria: * Patient under 18 years of age * Has no suspicion or diagnosis of a pancreatic cancer or tumor * Self-reported race/ethnicity other than African American or Non-Hispanic White.
Contact & Investigator
Jennifer Permuth, PhD, MS
PRINCIPAL INVESTIGATOR
Moffitt Cancer Center
Frequently Asked Questions
Who can join the NCT05687188 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pancreatic Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05687188 currently recruiting?
Yes, NCT05687188 is actively recruiting participants. Visit ClinicalTrials.gov or contact H. Lee Moffitt Cancer Center and Research Institute to inquire about joining.
Where is the NCT05687188 trial being conducted?
This trial is being conducted at Tampa, United States, Jackson, United States.
Who is sponsoring the NCT05687188 clinical trial?
NCT05687188 is sponsored by H. Lee Moffitt Cancer Center and Research Institute. The principal investigator is Jennifer Permuth, PhD, MS at Moffitt Cancer Center. The trial plans to enroll 125 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.